Exceptional Response to Nivolumab and Stereotactic Body Radiation Therapy (SBRT) in Neuroendocrine Cervical Carcinoma with High Tumor Mutational Burden: Management Considerations from the Center For Personalized Cancer Therapy at UC San Diego Moores (Q38760780)
Jump to navigation
Jump to search
scientific article published on 26 May 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Exceptional Response to Nivolumab and Stereotactic Body Radiation Therapy (SBRT) in Neuroendocrine Cervical Carcinoma with High Tumor Mutational Burden: Management Considerations from the Center For Personalized Cancer Therapy at UC San Diego Moores |
scientific article published on 26 May 2017 |
Statements
1 reference
Exceptional Response to Nivolumab and Stereotactic Body Radiation Therapy (SBRT) in Neuroendocrine Cervical Carcinoma with High Tumor Mutational Burden: Management Considerations from the Center For Personalized Cancer Therapy at UC San Diego Moores (English)
1 reference
Razelle Kurzrock
1 reference
Andrew Sharabi
1 reference
Sangwoo Shawn Kim
1 reference
Shumei Kato
1 reference
Philip D Sanders
1 reference
Sandip Pravin Patel
1 reference
Parag Sanghvi
1 reference
Elizabeth Weihe
1 reference
26 May 2017
1 reference
1 reference
631-637
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference